Background The Xpert MTB/RIF assay is an automated molecular test that has improved the
detection of tuberculosis and rifampicin resistance, but its sensitivity is inadequate in …

Xpert MTB/RIF (Cepheid, Sunnyvale, CA, USA) is endorsed for the detection of pulmonary
tuberculosis (TB). We performed a systematic review and meta-analysis to assess the …

The Xpert MTB/RIF assay (Xpert) is a rapid test for tuberculosis (TB) and rifampin resistance
(RIF-R) suitable for point-of-care testing. However, it has decreased sensitivity in smear-…

Tuberculosis (TB) is the leading infectious cause of mortality worldwide, due in part to a
limited understanding of its clinical pathogenic spectrum of infection and disease. Historically, …

Background Tuberculosis (TB) is the world’s leading infectious cause of death. Extrapulmonary
TB accounts for 15% of TB cases, but the proportion is increasing, and over half a million …

Background Xpert MTB/RIF (Xpert MTB/RIF) and Xpert MTB/RIF Ultra (Xpert Ultra), the
newest version, are the only World Health Organization (WHO)‐recommended rapid tests that …

Background: Diagnosis of chronic hepatitis C virus (HCV) infection requires both a positive
HCV antibody screen and confirmatory nucleic acid testing (NAT). Testing for hepatitis C virus …

Molecular tests for tuberculosis (TB) have the potential to help reach the three million people
with TB who are undiagnosed or not reported each year and to improve the quality of care …

Only 25% of multidrug-resistant tuberculosis (MDR-TB) cases are currently diagnosed. Line
probe assays (LPAs) enable rapid drug-susceptibility testing for rifampicin (RIF) and …

Background Xpert MTB/RIF Ultra (Xpert Ultra) and Xpert MTB/RIF are World Health Organization
(WHO)‐recommended rapid nucleic acid amplification tests (NAATs) widely used for …